| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/06/1994 | WO1994000748A1 Bioassay for the screening of ion channel active molecules |
| 01/06/1994 | WO1994000531A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 01/06/1994 | WO1994000530A1 Luminescent article with high phosphor to binder ratio and manufacture thereof |
| 01/06/1994 | WO1994000491A1 INTERLEUKIN-1β DELETION MUTANT |
| 01/06/1994 | WO1994000485A1 Multimeric forms of human rhinovirus receptor protein |
| 01/06/1994 | WO1994000481A1 Pharmaceutical composition containing botulinum b complex |
| 01/06/1994 | WO1994000164A1 Sustained release alginate fibre and process for the preparation thereof |
| 01/06/1994 | WO1994000156A1 Polymer-bound paclitaxel derivatives |
| 01/06/1994 | WO1994000155A1 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments |
| 01/06/1994 | WO1994000142A1 Emulsified preparation of aureobasidin |
| 01/06/1994 | WO1994000128A1 ORAL 1α-HYDROXYPREVITAMIN D |
| 01/06/1994 | WO1994000111A1 Spheronization process using charged resins |
| 01/06/1994 | WO1994000109A1 Dermatological agent for aiding oxygen transport in the skin |
| 01/06/1994 | WO1994000101A1 Prophylactic and therapeutical preparation against caries |
| 01/06/1994 | WO1994000098A1 Cosmetic containing phospholipids and fluorocarbon compounds |
| 01/06/1994 | WO1994000097A1 Topical application composition |
| 01/06/1994 | WO1994000011A1 Starch-iodine-peroxide preservation of blood, tissues and biological fluids |
| 01/06/1994 | CA2138780A1 Prophylactic and therapeutical preparation against caries |
| 01/06/1994 | CA2138380A1 Bioassay for the screening of ion channel active molecules |
| 01/06/1994 | CA2136435A1 Spheronization process using charged resins |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/06/1994 | CA2112482A1 Polymer-bound paclitaxel derivatives |
| 01/05/1994 | EP0577504A1 Niacin-containing sustained-release tablets and kits |
| 01/05/1994 | EP0577225A1 Diagnosis and treatment of inflammation |
| 01/05/1994 | EP0577215A1 Surface modified anticancer nanoparticles |
| 01/05/1994 | EP0577146A2 Liposomes coupled to hormones |
| 01/05/1994 | EP0577143A2 Solid and liquid solutions of flavonoids |
| 01/05/1994 | EP0576612A1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 01/05/1994 | EP0576605A1 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| 01/05/1994 | EP0576589A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 01/05/1994 | EP0576551A1 Novel encapsulated materials. |
| 01/05/1994 | EP0576537A1 Debridement of bodily cavities using debridement fluids |
| 01/05/1994 | EP0576521A1 Improvements in or relating to contrast agents. |
| 01/05/1994 | EP0487615B1 Ferritin analogs |
| 01/05/1994 | DE4221880A1 Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen Solid and liquid solutions of poorly water-soluble drugs |
| 01/05/1994 | DE4221268A1 Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut Using a dermatological to support the oxygen transport into skin |
| 01/05/1994 | DE4221255A1 Phospholipide enthaltendes Kosmetikum Phospholipids containing cosmetic |
| 01/05/1994 | DE4221054A1 Präparat zur prophylaktischen und therapeutischen Behandlung von Karies sowie Verfahren zum Herstellen desselben Of the same compound for the prophylactic and therapeutic treatment of caries as well as methods for preparing |
| 01/04/1994 | US5276044 Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions |
| 01/04/1994 | US5276032 For topical application to human lesion caused by papillomavirus |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275838 Immobilized polyethylene oxide star molecules for bioapplications |
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 01/04/1994 | US5275822 Dry, uniform, free-flowing granular carbohydrate agglomerate; hydrocarbon, mineral or silicone oils containing silica |
| 01/04/1994 | US5275820 Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles |
| 01/04/1994 | CA1325803C Useful compounds in particular for cancer radiotherapy and imagery and new steroid hormone receptors specific ligands |
| 01/04/1994 | CA1325707C Granular tricalcium phosphate compositions suitable for direct compression tableting |
| 12/29/1993 | EP0576279A1 Hydrophilic cream for the delivery of therapeutic agents |
| 12/29/1993 | EP0576192A2 Polyoxymethylene-oxyethylene copolymers in conjunction with biomolecules |
| 12/29/1993 | EP0575977A2 Chewing gum compositions |
| 12/29/1993 | EP0575976A1 Inclusion complexes of polymerized cyclodextrins with pharmaceutical drugs |
| 12/29/1993 | EP0575930A1 Process for the preparation of solid sustained release pharmaceutical forms |
| 12/29/1993 | EP0575841A1 Composition containing dibucaine hydrochloride, a salicylate, calcium bromide and an antiphlopstic steroid for the treatment of pain |
| 12/29/1993 | EP0575613A1 Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
| 12/29/1993 | EP0575581A1 Novel cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels |
| 12/29/1993 | EP0575556A1 Palytoxin-related prodrugs and a method for their administration |
| 12/29/1993 | EP0575545A1 Pegylation of polypeptides |
| 12/29/1993 | EP0575321A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
| 12/29/1993 | EP0429442B1 Dental therapy by vesicle delivery |
| 12/29/1993 | EP0280703B1 Compositions comprising 1-acyl-substituted morpholines, thiomorpholines and piperazines and their uses |
| 12/29/1993 | CN1079971A Polymer-bound taxol derivatives |
| 12/29/1993 | CN1079967A Method for producing carbohydrates |
| 12/29/1993 | CN1079896A Topical aromatic releasing compositions |
| 12/29/1993 | CN1023293C Controlling-release preparation |
| 12/28/1993 | US5274075 Newly identified human epsilon immunoglobulin peptides and related products |
| 12/28/1993 | US5273965 A reduced and hydrolyzed saponin from a Quillaja saponaria extract |
| 12/28/1993 | US5273953 Pesticidal compositions comprising ethoxylated citric or tartaric acid derivatives as stabilizing surfactants |
| 12/28/1993 | US5273760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 12/28/1993 | US5273743 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
| 12/28/1993 | US5273742 Replacing ocular fluid in a mammal eye using an aqueous solution of hydrogel polyoxyethylene glycol polyurethane; nontoxic |
| 12/28/1993 | CA1325600C Anticariogenic compositions |
| 12/28/1993 | CA1325599C Cosmetic composition |
| 12/27/1993 | CA2096690A1 Hydrophilic creams for delivery of therapeutic agents |
| 12/23/1993 | WO1993026019A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 12/23/1993 | WO1993025673A1 In vivo gene therapy with intron-free sequence of interest |
| 12/23/1993 | WO1993025583A2 Proteinoid carriers and methods for preparation and use thereof |
| 12/23/1993 | WO1993025247A1 Immobilized polyethylene oxide star molecules for bioapplications |
| 12/23/1993 | WO1993025242A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 12/23/1993 | WO1993025241A1 Use of microcapsules as contrasting agents in colour doppler sonography |
| 12/23/1993 | WO1993025240A2 Pretargeting methods and compounds |
| 12/23/1993 | WO1993025239A1 Arabinogalactan derivatives and uses thereof |
| 12/23/1993 | WO1993025238A1 Stable imidazole anti-fungal powder compositions |
| 12/23/1993 | WO1993025234A1 Methods and compositions for targeting specific tissue |
| 12/23/1993 | WO1993025225A1 Liposomal formulations for administering to cancer patients |
| 12/23/1993 | WO1993025222A1 Stabilized somatotropin for parenteral administration |
| 12/23/1993 | WO1993025221A1 Erythropoietin drug delivery system |
| 12/23/1993 | WO1993025212A1 Polyoxymethylene-oxyethylene copolymers in conjunction with biomolecules |
| 12/23/1993 | WO1993025210A1 Diphtheria toxin vaccines |
| 12/23/1993 | WO1993025209A1 Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof |
| 12/23/1993 | WO1993025204A1 Gastro-protected stable omeprazole compositions in the form of microgranules and process for their production |
| 12/23/1993 | WO1993025198A1 Ultrafine powder for inhalation and production thereof |
| 12/23/1993 | WO1993025197A1 Compositions and methods for enhanced drug delivery |
| 12/23/1993 | WO1993025195A1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres |
| 12/23/1993 | WO1993025194A1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules |
| 12/23/1993 | WO1993025192A1 Pharmaceutical compositions containing nsaid and bile acids |
| 12/23/1993 | WO1993025191A2 Bioresorbable polymer microspheres free from surface active agents, their preparation and application as drug |
| 12/23/1993 | WO1993025190A1 Surface modified nsaid nanoparticles |
| 12/23/1993 | WO1993025188A1 Lenitive composition and method |
| 12/23/1993 | WO1993025168A1 The use of glycerin in moderating transdermal drug delivery |
| 12/23/1993 | CA2138277A1 Polyoxymethylene-oxyethylene copolymers in conjunction with biomolecules |